Litcius/Paper detail

Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study

Yoko Tsukita, Takaya Yamamoto, Hiroshi Mayahara, Akito Hata, Yuichiro Takeda, Hidetsugu Nakayama, Satoshi Tanaka, Junji Uchida, Kazuhiro Usui, Tatsuya Toyoda, Motohiro Tamiya, Masahiro Morimoto, Yuko Oya, Takeshi Kodaira, Eisaku Miyauchi, Keiichi Jingu, Hisatoshi Sugiura

2021Radiotherapy and Oncology42 citationsDOI

Topics & Concepts

DurvalumabMedicinePneumonitisRadiation therapyLung cancerInternal medicineChemoradiotherapyRetrospective cohort studyStage (stratigraphy)Multivariate analysisOncologyIncidence (geometry)CancerLungNivolumabImmunotherapyPhysicsPaleontologyOpticsBiologyLung Cancer Diagnosis and TreatmentEffects of Radiation ExposureCancer Immunotherapy and Biomarkers
Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study | Litcius